Drug interaction study in healthy adults
Treatments studied
This study checks how a drug called engasertib is processed in the body when it's taken with itraconazole, a common antifungal that can affect drug levels. It is a phase 1 trial for healthy adults, helping researchers understand safe dosing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- You must be generally healthy with no major medical conditions (like heart, liver, kidney, thyroid, or blood sugar problems).
- You must weigh at least 50 kg (about 110 lbs) and have a body mass index (BMI) between 18 and 30.
- You must not smoke or use nicotine products (like patches or e-cigarettes) for at least 3 months before the study.
- You must be willing to use effective contraception or be abstinent if you are fertile.
- You must be able to take oral medications and not have lactose intolerance or difficulty swallowing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether a common antifungal drug (itraconazole) affects how the body processes a new experimental medicine (HS-10506). The goal is to see if the two drugs can be used together safely.
This study tests how a medication called itraconazole affects the levels of a new drug called HS-10504 in your body. It aims to see if taking these together changes how the new drug is absorbed or processed, which helps decide safe dosing for future patients.
This study tests a new medicine called Lu AH69593 in healthy people to see how safe it is and how the body handles it. Participants will stay at the clinic for a short time. This is an early-stage trial, so it may not directly help you, but it helps develop future treatments.
This study tests how two other drugs affect the levels of the study drug pelabresib in healthy people. It aims to see if taking these drugs together changes how the body processes pelabresib.
This study checks if stomach acid medicine and another drug affect how the body handles a new investigational drug. It helps researchers understand dosing for future patients.
This trial checks if a new drug (AZD4144) works differently when taken with an antifungal medicine (itraconazole) in healthy volunteers. It helps doctors understand how to adjust doses for people who need both medicines.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.